Vertex Pharmaceuticals Inc
VRTX· Nasdaq
Released Nov 6, 2023, after the close
10-Q filed Nov 7, 2023, 38 days after period end · 0000875320-23-000031
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $2.48B | $2.33B | $1.98B | $1.54B |
| Net Income | $1.04B | $930.50M | $851.90M | $667.43M |
| EPS Diluted |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| $3.97 |
| $3.59 |
| $3.28 |
| $2.53 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.